The landscape of dementia diagnosis has progressed radically with the arrival of refined biomarkers, such as amyloid PET scans, tau imaging, and blood-based assessments that will detect Alzheimer's pathology many years right before signs or symptoms emerge. When these technological improvements represent amazing progress in being familiar with neurodegenerative conditions, https://englandm133dzv0.wiki-jp.com/user